Protocol and statistical analysis plan for the REstricted fluid therapy VERsus Standard trEatment in Acute Kidney Injury-REVERSE-AKI randomized controlled pilot trial
Suvi T Vaara, Marlies Ostermann, Tuomas Selander, Laurent Bitker, Antoine Schneider, Elettra Poli, Eric Hoste, Michael Joannidis, Alexander Zarbock, Frank van Haren, John Prowle, Ville Pettilä, Rinaldo Bellomo, Suvi T Vaara, Marlies Ostermann, Tuomas Selander, Laurent Bitker, Antoine Schneider, Elettra Poli, Eric Hoste, Michael Joannidis, Alexander Zarbock, Frank van Haren, John Prowle, Ville Pettilä, Rinaldo Bellomo
Abstract
Background: Fluid accumulation frequently coexists with acute kidney injury (AKI) and is associated with increased risk for AKI progression and mortality. Among septic shock patients, restricted use of resuscitation fluid has been reported to reduce the risk of worsening of AKI. Restrictive fluid therapy, however, has not been studied in the setting of established AKI. Here, we present the protocol and statistical analysis plan of the REstricted fluid therapy VERsus Standard trEatment in Acute Kidney Injury-the REVERSE-AKI trial that compares a restrictive fluid therapy regimen to standard therapy in critically ill patients with AKI.
Methods: REVERSE-AKI is an investigator-initiated, multinational, open-label, randomized, controlled, feasibility pilot trial conducted in seven ICUs in five countries. We aim to randomize 100 critically ill patients with AKI to a restrictive fluid treatment regimen vs standard management. In the restrictive fluid therapy regimen, the daily fluid balance target is neutral or negative. The primary outcome is the cumulative fluid balance assessed after 72 hours from randomization. Secondary outcomes include safety, feasibility, duration, and severity of AKI, and outcome at 90 days (mortality and dialysis dependence).
Conclusions: This is the first multinational trial investigating the feasibility and safety of a restrictive fluid therapy regimen in critically ill patients with AKI.
Trial registration: clinical.trials.gov NCT03251131.
Keywords: acute kidney injury; critically ill; fluid balance; restrictive fluid therapy.
Conflict of interest statement
The authors report no conflict of interest.
© 2020 The Authors. Acta Anaesthesiologica Scandinavica published by John Wiley & Sons Ltd on behalf of Acta Anaesthesiologica Scandinavica Foundation.
References
- Nisula S, Kaukonen KM, Vaara ST, et al. Incidence, risk factors and 90‐day mortality of patients with acute kidney injury in Finnish intensive care units: the FINNAKI study. Intensive Care Med. 2013;39:420‐428.
- Hoste EA, Bagshaw SM, Bellomo R, et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI‐EPI study. Intensive Care Med. 2015;41:1411‐1423.
- Prowle JR, Kirwan CJ, Bellomo R. Fluid management for the prevention and attenuation of acute kidney injury. Nat Rev Nephrol. 2014;10:37‐47.
- Ostermann M, Liu K, Kashani K. Fluid management in acute kidney injury. Chest. 2019;156:594‐603.
- RENAL T . observational study fluid balance and patient outcomes in the randomized evaluation of normal vs. augmented level of replacement therapy trial*. Crit Care Med. 2012;40:1753‐1760.
- Raimundo M, Crichton S, Martin JR, et al. Increased fluid administration after early acute kidney injury is associated with less renal recovery. Shock (Augusta, Ga). 2015;44:431‐437.
- Zhang J, Crichton S, Dixon A, Seylanova N, Peng ZY, Ostermann M. Cumulative fluid accumulation is associated with the development of acute kidney injury and non‐recovery of renal function: a retrospective analysis. Crit Care. 2019;23:392.
- Prowle JR, Echeverri JE, Ligabo EV, Ronco C, Bellomo R. Fluid balance and acute kidney injury. Nat Rev Nephrol. 2010;6:107‐115.
- Vaara ST, Korhonen AM, Kaukonen KM, et al. Fluid overload is associated with an increased risk for 90‐day mortality in critically ill patients with renal replacement therapy: data from the prospective FINNAKI study. Crit Care. 2012;16:R197.
- Grams ME, Estrella MM, Coresh J, Brower RG, Liu KD. Fluid balance, diuretic use, and mortality in acute kidney injury. Clin J Am Soc Nephrol. 2011;6:966‐973.
- Bouchard J, Soroko SB, Chertow GM, et al. Fluid accumulation, survival and recovery of kidney function in critically ill patients with acute kidney injury. Kidney Int. 2009;76:422‐427.
- Hjortrup PB, Haase N, Bundgaard H, et al. Restricting volumes of resuscitation fluid in adults with septic shock after initial management: the CLASSIC randomised, parallel‐group, multicentre feasibility trial. Intensive Care Med. 2016;42:1695‐1705.
- Chen C, Kollef MH. Targeted fluid minimization following initial resuscitation in septic shock: A pilot study. Chest. 2015;148:1462‐1469.
- Wiedemann HP, Wheeler AP, Bernard GR, et al. Comparison of two fluid‐management strategies in acute lung injury. N Engl J Med. 2006;354:2564‐2575.
- Myles PS, Bellomo R, Corcoran T, et al. Restrictive versus liberal fluid therapy for major abdominal surgery. N Engl J Med. 2018;378:2263‐2274.
- Kellum JA, Lameire N, Aspelin P, et al. Kidney diseases: improving global outcomes (KDIGO) acute kidney Injury workgroup: KDIGO clinical practice guideline for acute kidney injury. Kidney Inter Suppl. 2012;1‐138.
- Pickkers P, Ostermann M, Joannidis M, et al. The intensive care medicine agenda on acute kidney injury. Intensive Care Med. 2017;43(9):1198‐1209.
- Chan AW, Tetzlaff JM, Altman DG, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158:200‐207.
- Liu KD, Thompson BT, Ancukiewicz M, et al. Acute kidney injury in patients with acute lung injury: impact of fluid accumulation on classification of acute kidney injury and associated outcomes. Crit Care Med. 2011;39:2665‐2671.
- Schulz KF, Altman DG, Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med. 2010;152:726‐732.
- Hoste EA, Maitland K, Brudney CS, et al. Four phases of intravenous fluid therapy: a conceptual model. Br J Anaesth. 2014;113:740‐747.
Source: PubMed